. Author manuscript; available in PMC: 2014 Jun 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Apr 12;22(6):1118–1128. doi: 10.1158/1055-9965.EPI-12-1316

Table 2.

Adjusted odds ratios and 95% confidence intervals for the association between quartiles of UV radiation exposure based on mother’s address at birth and cancer in offspring ages 0–5 in California (1986–2007)

		Adjusted for birth year (controls n=207308)			Adjusted for mother’s age, race, and child’s birth year (controls n=203018)

Cancer	UV quartiles^a (Watt hrs/m²)	Cases (n)	OR	95 %CI	Cases (n)	OR	95 %CI	Trend p-value
ALL		3396			3324
	Q1		ref			ref
	Q2		0.93	(0.85, 1.03)		0.91	(0.83, 1.01)
	Q3		1.03	(0.94, 1.13)		0.97	(0.88, 1.07)
	Q4		0.93	(0.84, 1.02)		0.89	(0.81, 0.99)	0.042
AML		565			552
	Q1		ref			ref
	Q2		0.99	(0.78, 1.24)		1.00	(0.79, 1.26)
	Q3		1.02	(0.81, 1.29)		1.00	(0.79, 1.27)
	Q4		0.87	(0.69, 1.11)		0.90	(0.70, 1.15)	0.447
Astrocytoma		801			789
	Q1		ref			ref
	Q2		0.82	(0.67, 1.00)		0.91	(0.75, 1.12)
	Q3		0.83	(0.68, 1.01)		0.92	(0.75, 1.12)
	Q4		0.92	(0.76, 1.11)		0.96	(0.79, 1.17)	0.648
Bone tumors		79			78
	Q1		ref			ref
	Q2		0.83	(0.41, 1.67)		0.80	(0.39, 1.65)
	Q3		1.47	(0.80, 2.73)		1.37	(0.73, 2.57)
	Q4		1.37	(0.73, 2.57)		1.22	(0.64, 2.32)	0.411
Other gliomas		220			217
	Q1		ref			ref
	Q2		0.93	(0.65, 1.33)		0.99	(0.68, 1.43)
	Q3		0.80	(0.55, 1.16)		0.90	(0.61, 1.32)
	Q4		0.82	(0.57, 1.19)		0.91	(0.62, 1.32)	0.568
Ependymoma and choroid plexus tumors		244			241
	Q1		ref			ref
	Q2		1.04	(0.74, 1.46)		1.08	(0.76, 1.53)
	Q3		0.89	(0.63, 1.27)		0.92	(0.64, 1.33)
	Q4		0.84	(0.59, 1.21)		0.88	(0.61, 1.27)	0.465
Hepatoblastoma		258			256
	Q1		ref			ref
	Q2		0.95	(0.69, 1.32)		0.95	(0.68, 1.32)
	Q3		0.85	(0.61, 1.19)		0.82	(0.58, 1.16)
	Q4		0.7	(0.49, 1.00)		0.69	(0.48, 1.00)	0.044
Hodgkin’s lymphoma		62			62
	Q1		ref			ref
	Q2		1.19	(0.51, 2.75)		0.90	(0.38, 2.10)
	Q3		2.33	(1.11, 4.89)		1.72	(0.81, 3.66)
	Q4		1.7	(0.78, 3.71)		1.32	(0.60, 2.92)	0.345
Non-Hodgkin’s lymphoma		271			268
	Q1		ref			ref
	Q2		0.80	(0.57, 1.12)		0.84	(0.60, 1.18)
	Q3		1.01	(0.73, 1.38)		1.05	(0.76, 1.45)
	Q4		0.72	(0.51, 1.01)		0.71	(0.50, 1.02)	0.119
Intracranial and intraspinal embryonal tumors		559			550
	Q1		ref			ref
	Q2		1.19	(0.94, 1.52)		1.26	(0.98, 1.61)
	Q3		1.14	(0.89, 1.45)		1.20	(0.93, 1.54)
	Q4		1.26	(1.00, 1.61)		1.29	(1.01, 1.65)	0.047
Other intracranial and intraspinal neoplasms		113			108
	Q1		ref			ref
	Q2		0.82	(0.48, 1.39)		0.95	(0.55, 1.66)
	Q3		0.93	(0.56, 1.55)		1.05	(0.62, 1.80)
	Q4		0.92	(0.55, 1.54)		1.05	(0.61, 1.79)	0.839
Neuroblastoma		1070			1042
	Q1		ref			ref
	Q2		0.81	(0.68, 0.96)		0.90	(0.76, 1.07)
	Q3		0.81	(0.68, 0.95)		0.91	(0.77, 1.09)
	Q4		0.87	(0.74, 1.03)		0.93	(0.79, 1.11)	0.385
Rhabdomyosarcoma		364			352
	Q1		ref			ref
	Q2		1.17	(0.89, 1.55)		1.22	(0.91, 1.63)
	Q3		0.92	(0.68, 1.23)		1.01	(0.74, 1.37)
	Q4		0.88	(0.65, 1.19)		0.97	(0.71, 1.33)	0.804
Other soft tissue sarcomas		140			136
	Q1		ref			ref
	Q2		1.14	(0.69, 1.90)		1.08	(0.64, 1.82)
	Q3		1.54	(0.96, 2.48)		1.49	(0.92, 2.43)
	Q4		1.33	(0.82, 2.18)		1.26	(0.77, 2.09)	0.260
Wilms’ tumor		824			812
	Q1		ref			ref
	Q2		0.90	(0.75, 1.09)		0.91	(0.75, 1.11)
	Q3		0.83	(0.68, 1.00)		0.87	(0.71, 1.06)
	Q4		0.91	(0.75, 1.09)		0.92	(0.76, 1.12)	0.335
Germ cell tumors		370			363
	Q1		ref			ref
	Q2		1.10	(0.83, 1.46)		1.17	(0.88, 1.57)
	Q3		1.12	(0.85, 1.49)		1.17	(0.87, 1.56)
	Q4		0.86	(0.63, 1.16)		0.9	(0.66, 1.23)	0.666
Retinoblastoma		606			591
	Q1		ref			ref
	Q2		1.02	(0.81, 1.27)		1.03	(0.82, 1.30)
	Q3		1.008	(0.81, 1.26)		1.03	(0.82, 1.30)
	Q4		0.877	(0.70, 1.10)		0.88	(0.69, 1.11)	0.338

Q1: 3133 – 4946; Q2: >4946 – 5030; Q3: >5030 – 5111; Q4: >5111 – 5804 Watt-hrs/m².